Today in News History
On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1884, Louis B. Mayer, Russian-born American film producer, co-founded Metro-Goldwyn-Mayer (died 1957) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1925, Roger Smith, American businessman (died 2007) was born. In 1948, Richard Simmons, American fitness trainer and actor (died 2024) was born. In 1949, Rick Hendrick, American businessman, founded Hendrick Motorsports was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1982, Jason Wright, American football player, businessman, and executive was born. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2024, Ruth Westheimer, German-American sex therapist (born 1928) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
H.C. Wainwright reiterates Buy on LENZ Therapeutics stock on telehealth launch
Narrative Intelligence Brief
This article was published by Investing.com, a source frequently categorized with a center bias based in Israel. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Investing.com, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Investing.com
July 12, 2026
Geopolitical risks are reshaping investment strategies, WSJ analysis says
July 12, 2026
Japan to steer $1.8 trillion pension fund toward more alternative investments
July 12, 2026
What’s the AI hit to U.S. inflation?
July 12, 2026
US says it struck 140 Iranian military targets Saturday
July 12, 2026
Japan to push its massive pension fund to boost alternative investments, Nikkei says
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"england"
Tuchel angry at 'lucky' England - but Bellingham defends players
Tuchel angry at 'lucky' England - but Bellingham defends players
‘A dangerous movie’: Glenn Beck warns ‘Citizen Vigilante’ signals a dark moral shift after Germany bans it
How other outlets are covering this story
Compare narratives across 5 related reports from 5 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
5 sources
Left 40%
Center 20%
Right 40%
Investing.com
· Jul 7, 2026
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress
H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress
The Motley Fool
· Jul 2, 2026
Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?
It could be an attractive contrarian play, but beware of the risks.
The Hindu BusinessLine
· Jul 7, 2026
Stock to buy today: Glenmark Pharmaceuticals (₹2,270) – BUY
Glenmark Pharmaceuticals share price can rise to 2,500
The Next Web
· Jul 8, 2026
ResMed sells its MatrixCare software business to Frazier for $490m
ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to the private equity firm Frazier Healthcare Partners for 490m in cash. The deal lets the medical-device maker part with a unit it had owned for years to focus on the machines that remain its core. MatrixCare is a decent-sized business in its [] This story continues at The Next Web
Seeking Alpha
· Jun 25, 2026
Crinetics Pharmaceuticals: 'Buy' On Palsonify Market Expansion And Atumelnant Advancements
Crinetics Pharmaceuticals: 'Buy' On Palsonify Market Expansion And Atumelnant Advancements
Topics:
Related coverage for "H.C. Wainwright reiterates Buy on LENZ Therapeutics stock on telehealth launch": Investing.com — H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on FDA trial progress. The Motley Fool — Teladoc's Recovery Story Is Starting to Take Shape. Should You Buy the Stock?. The Hindu BusinessLine — Stock to buy today: Glenmark Pharmaceuticals (₹2,270) – BUY. The Next Web — ResMed sells its MatrixCare software business to Frazier for $490m. Seeking Alpha — Crinetics Pharmaceuticals: 'Buy' On Palsonify Market Expansion And Atumelnant Advancements